Literature DB >> 33539226

Is the Debate on the Flecainide Action on the RYR2 in CPVT Closed?

Jean-Pierre Benitah1, Ana M Gómez1.   

Abstract

Entities:  

Keywords:  Editorials; arrhythmias; calcium; flecainide; heart diseases

Mesh：

Substances：

Year:  2021        PMID： 33539226      PMCID： PMC7869569          DOI： 10.1161/CIRCRESAHA.121.318706

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  18 in total

1.  Intracellular calcium release channels mediate their own countercurrent: the ryanodine receptor case study.

Authors:  Dirk Gillespie; Michael Fill
Journal:  Biophys J       Date:  2008-07-11       Impact factor: 4.033

Review 2.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

Authors:  Silvia G Priori; Arthur A Wilde; Minoru Horie; Yongkeun Cho; Elijah R Behr; Charles Berul; Nico Blom; Josep Brugada; Chern-En Chiang; Heikki Huikuri; Prince Kannankeril; Andrew Krahn; Antoine Leenhardt; Arthur Moss; Peter J Schwartz; Wataru Shimizu; Gordon Tomaselli; Cynthia Tracy
Journal:  Heart Rhythm       Date:  2013-08-30       Impact factor: 6.343

Review 3.  Catecholaminergic polymorphic ventricular tachycardia: a model for genotype-specific therapy.

Authors:  Thomas M Roston; Filip Van Petegem; Shubhayan Sanatani
Journal:  Curr Opin Cardiol       Date:  2017-01       Impact factor: 2.161

4.  Modernized Classification of Cardiac Antiarrhythmic Drugs.

Authors:  Ming Lei; Lin Wu; Derek A Terrar; Christopher L-H Huang
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

5.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.

Authors:  Hiroshi Watanabe; Nagesh Chopra; Derek Laver; Hyun Seok Hwang; Sean S Davies; Daniel E Roach; Henry J Duff; Dan M Roden; Arthur A M Wilde; Björn C Knollmann
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

Review 6.  Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.

Authors:  Samantha C Salvage; Karthik H Chandrasekharan; Kamalan Jeevaratnam; Angela F Dulhunty; Andrew J Thompson; Antony P Jackson; Christopher L-H Huang
Journal:  Br J Pharmacol       Date:  2017-05-12       Impact factor: 8.739

7.  The direct actions of flecainide on the human cardiac ryanodine receptor: keeping open the debate on the mechanism of action of local anesthetics in CPVT.

Authors:  Godfrey L Smith; Niall MacQuaide
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

8.  Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.

Authors:  Eleonora Savio-Galimberti; Björn C Knollmann
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

9.  Effect of flecainide derivatives on sarcoplasmic reticulum calcium release suggests a lack of direct action on the cardiac ryanodine receptor.

Authors:  Mark L Bannister; Anita Alvarez-Laviada; N Lowri Thomas; Sammy A Mason; Sharon Coleman; Christo L du Plessis; Abbygail T Moran; David Neill-Hall; Hasnah Osman; Mark C Bagley; Kenneth T MacLeod; Christopher H George; Alan J Williams
Journal:  Br J Pharmacol       Date:  2016-06-29       Impact factor: 8.739

10.  Tracking the sarcoplasmic reticulum membrane voltage in muscle with a FRET biosensor.

Authors:  Colline Sanchez; Christine Berthier; Bruno Allard; Jimmy Perrot; Clément Bouvard; Hidekazu Tsutsui; Yasushi Okamura; Vincent Jacquemond
Journal:  J Gen Physiol       Date:  2018-06-13       Impact factor: 4.086
View more
  1 in total

Review 1.  Molecular, Subcellular, and Arrhythmogenic Mechanisms in Genetic RyR2 Disease.

Authors:  Ewan Douglas Fowler; Spyros Zissimopoulos
Journal:  Biomolecules       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.